Development of Inactivated FAKHRAVAC ® Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
SARS-COV-2 바이러스에 대한 불활성 Fakhravac ® 백신의 개발 : 동물 모델의 전임상 연구
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
animal
animals
BALB/c mice
breath
caused
clinical evaluation
clinical manifestation
clinical trial
conducted
coronavirus
country
COVID-19
development
disease
effective vaccine
Effective vaccines
eligibility
FAKHRAVAC
FIVE
global public health
group
guinea pigs
Health crisis
High
Immunity
immunization
inactivated
induce
infected case
Iran
medium
mice
Model
Neutralizing
Neutralizing antibodies
neutralizing antibody
non-human primate
non-human primates
pandemic
Patient
PIGS
potency
Preclinical
preclinical study
produced
purified
reached
reported
respiratory
rhesus macaques
SARS-CoV-2
SARS-CoV-2 strains
SARS-CoV-2 vaccine
SARS-CoV-2 virus
seroconversion rate
severe acute respiratory syndrome Coronavirus
Support
tested
These data
Vaccine
vaccine candidate
Vaccine development
Viral
viral infection
viral strain
viral strains
[DOI] 10.3390/vaccines9111271 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/vaccines9111271 PMC 바로가기 [Article Type] Article